Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Calza

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
European Journal of Clinical Pharmacology|September 30, 2010
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patientsLeonardo Calza, Laura Mosca, Daria Pocaterra, et al.
HIV Clinical Trials|February 13, 2014
Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patientsLeonardo Calza, Elisa Vanino, Caterina Salvadori, et al.
Le Infezioni in Medicina|March 31, 2015
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issuesRoberto Manfredi, Leonardo Calza, Ginevra Marinacci, et al.
Le Infezioni in Medicina|March 22, 2014
Integration among hospital pharmacists and infectious diseases physicians in the outpatient management of HIV infectionLucia Appolloni, Federica Locchi, Nicolò Girometti, et al.
AIDS Research and Human Retroviruses|November 5, 2014
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort studyLeonardo Calza, Ilaria Danese, Vincenzo Colangeli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 20, 2013
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infectionIsabella Bon, Alberto Clò, Marco Borderi, et al.
Clinical and Experimental Nephrology|July 22, 2019
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapyLeonardo Calza, Michele Sachs, Vincenzo Colangeli, et al.
AIDS Research and Human Retroviruses|October 27, 2012
Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular riskLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
HIV Clinical Trials|June 21, 2014
The problem of renal function monitoring in patients treated with the novel antiretroviral drugsPaolo Maggi, Vincenzo Montinaro, Stefano Rusconi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 29, 2020
SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?Maddalena Giglia, Giacomo Beci, Elena Rosselli Del Turco, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
European Journal of Clinical Pharmacology|September 30, 2010
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patientsLeonardo Calza, Laura Mosca, Daria Pocaterra, et al.
HIV Clinical Trials|February 13, 2014
Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patientsLeonardo Calza, Elisa Vanino, Caterina Salvadori, et al.
Le Infezioni in Medicina|March 31, 2015
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issuesRoberto Manfredi, Leonardo Calza, Ginevra Marinacci, et al.
Le Infezioni in Medicina|March 22, 2014
Integration among hospital pharmacists and infectious diseases physicians in the outpatient management of HIV infectionLucia Appolloni, Federica Locchi, Nicolò Girometti, et al.
AIDS Research and Human Retroviruses|November 5, 2014
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort studyLeonardo Calza, Ilaria Danese, Vincenzo Colangeli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 20, 2013
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infectionIsabella Bon, Alberto Clò, Marco Borderi, et al.
Clinical and Experimental Nephrology|July 22, 2019
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapyLeonardo Calza, Michele Sachs, Vincenzo Colangeli, et al.
AIDS Research and Human Retroviruses|October 27, 2012
Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular riskLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
HIV Clinical Trials|June 21, 2014
The problem of renal function monitoring in patients treated with the novel antiretroviral drugsPaolo Maggi, Vincenzo Montinaro, Stefano Rusconi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 29, 2020
SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?Maddalena Giglia, Giacomo Beci, Elena Rosselli Del Turco, et al.
Pageof 19